✦ LIBER ✦

616 POSTER Safety analysis of first-line bevacizumab plus chemotherapy in patients with metastatic colorectal cancer (mCRC) participating in a US registry

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

3049 POSTER Management of hypertension (

✍ M. Kozloff; J. Hainsworth; S. Badarinath; A. Cohn; P. Flynn; W. Dong; D. Purdie; 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 75 KB

3048 POSTER Safety and effectiveness of

✍ M. Sugrue; M. Kozloff; J. Hainsworth; S. Badarinath; A. Cohn; P. Flynn; W. Dong; 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 58 KB

Economic analysis of bevacizumab, cetuxi

✍ Lawrence, Donna; Maschio, Michael; Leahy, Kevin J.; Yunger, Simon; Easaw, Jacob 📂 Article 📅 2013 🏛 Informa plc 🌐 English ⚖ 466 KB

Multicenter phase II study of second-lin

✍ Yong Sang Hong, Jeeyun Lee, Kyu-pyo Kim, Jae-Lyun Lee, Young Suk Park, Joon Oh P 📂 Article 📅 2012 🏛 Springer US 🌐 English ⚖ 260 KB

6115 VEGF gene polymorphisms in the pred

✍ Loupakis, F.; Ruzzo, A.; Salvatore, L.; Canestrari, E.; Cremolini, C.; Santini, 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 48 KB

6060 KRAS and BRAF mutational analyses i

✍ Salvatore, L.; Loupakis, F.; Fontanini, G.; Cremolini, C.; Stasi, I.; Fabbri, A. 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 51 KB